Brookfield Corp’s Bristol-Myers Squibb BMY Stock Holding History

Brookfield Corp’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-18,603	Closed	-$1.19M	–	173
2023 Q2	$1.19M	Buy	18,603 +8,987	+93%	+$603K	﹤0.01%	454
2023 Q1	$666K	Buy	+9,616	New	+$678K	﹤0.01%	553
2022 Q3	–	Sell	-199,994	Closed	-$15.4M	–	642
2022 Q2	$15.4M	Buy	199,994 +153,715	+332%	+$11.7M	0.07%	106
2022 Q1	$3.38M	Buy	+46,279	New	+$3.11M	0.01%	324
2021 Q3	–	Sell	-50,996	Closed	-$3.41M	–	528
2021 Q2	$3.41M	Buy	+50,996	New	+$3.33M	0.02%	274

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Brookfield Corp's BMY Position: Q3 2023 in Review

Brookfield Corp sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 18,603 shares — an estimated $1.19M sold.

Brookfield Corp first reported a position in BMY in Q2 2021 and held it in 5 quarters. The position peaked at $15.4M in Q2 2022. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Brookfield Corp reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
Brookfield Corp sold 18,603 Bristol-Myers Squibb shares in Q3 2023, an estimated $1.19M.
Brookfield Corp first reported a position in Bristol-Myers Squibb in Q2 2021 and held it in 5 quarters.
Brookfield Corp's Bristol-Myers Squibb position peaked at $15.4M in Q2 2022.
2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.